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Accepted 16 February 2017Objective: Examine to what extent changes in cognitions and changes in physical activity and behavioural regu-
lation patterns influence fatigue severity, physical symptoms, and physical and psychological functioning of pa-
tients suffering from Chronic Fatigue Syndrome (CFS) at follow-up.
Methods: The present study is an observational longitudinal study with a 12-month follow-up. A total of 144 CFS
patients participated both at baseline and at follow-up. Four separate hierarchical regression analyses were con-
ducted with fatigue, physical symptoms, physical functioning and psychological functioning at follow-up as the
dependent variables, and (changes in) illness perceptions and behavioural regulation patterns (all-or-nothing
and limiting behaviour) as the independent variables. Data were collected making use of self-report question-
naires.
Results: Increased Consequence and Identity beliefs over time, as well as increases in all-or-nothing behaviour
predictedhigher fatigue severity at follow-up. Both number and severity of physical symptoms and psychological
functioning at follow-up were only determined by changes in illness perceptions, with increased Consequence
beliefs influencing both outcomes, and increased Timeline beliefs only determining physical symptoms. Physical
functioning at follow-upwas predicted by changes in illness perceptions aswell as increased levels of both all-or-
nothing and limiting behaviour.
Conclusion: The findings point at a differential pattern of associations between changes in illness perceptions and
behaviour regulation patterns on the one hand, and patient outcomes on the other hand.Whereas illness percep-
tions significantly contribute to each of the outcomes, behaviour regulation patterns contribute only to fatigue
severity and physical functioning.




Observational longitudinal study1. Introduction
Chronic Fatigue Syndrome (CFS) is characterized bymedically unex-
plained fatigue of at least six month duration, the fatigue has to be se-
vere, disabling and lead to a significant reduction in level of
occupational, personal and/or social functioning. CFS is diagnosed on
the basis of the Oxford criteria [1] or themore restrictive Center for Dis-
ease Control (CDC) criteria [2]. According to the CDC criteria, the patient
must also have reported at least four (out of eight) other somatic symp-
toms in addition to fatigue.
The prevalence of CFS ranges from0.6% to 2.5%, depending on the di-
agnostic criteria used, the setting (general population, primary, second-
ary, or tertiary care) and the country in which the studies were carriedof Psychology, Health, Medical
Leiden, The Netherlands.
ht).out [3,4]. CFS seems to affect mainly young adults from 20 to 40 years
old, the prevalence is two to three times higher in women, and seems
to be comparable across socio-economic groups [4]. The prognosis of
CFS is generally poor. In their review, Joyce and colleagues [5] state
that b10% of patients return to premorbid levels of functioning, a figure
that was confirmed by a 3-year follow-up study [6]. While full recovery
rates are low, there is a broader range in improvement rates among
studies ranging from 6 to 63% [5].
Theoretical frameworks for CFS usually distinguish between factors
that may render people more vulnerable to the development of CFS
(predisposing factors), factors that may trigger CFS (precipitating fac-
tors) and factors that maintain CFS and impede recovery (perpetuating
factors) [7,8]. The perpetuating factors are considered to bemost impor-
tant in viewof the development of interventions as theymay be respon-
sible for the maintenance and, eventually, worsening of fatigue
symptoms.
Existing models of perpetuating factors usually emphasize the role
of psychological processes, especially cognitions and behaviours, in
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of the two treatmentmodalities that are considered to be efficacious for
CFS according to the UK National Institute of Health and Clinical Excel-
lence (NICE) guidelines on CFS [11] and to a number of meta-analyses
on the subject [12–15]. These treatment modalities are: (a) Cognitive
Behaviour Therapy (CBT), focusing on challenging dysfunctional cogni-
tions related to fatigue/CFS, gradually increasing physical activity be-
haviour, and establishing a good activity/rest balance [16], and (b)
Graded Exercise Training (GET) solely focusing on physical activity be-
haviour [13].
Recently, the question has been raised to what extent cognitions
and behaviours mediate the effect of psychological and behavioural
interventions (such as CBT and GET) on fatigue severity and patient
functioning. On the basis of a re-analysis of three Randomized Con-
trolled Trials (RCTs), examining the role of physical activity as a me-
diator of the effect of CBT on fatigue severity [17], it was
demonstrated that changes in physical activity were not related to
changes in fatigue. A similar result was found in a study by Heins et
al. [18]. Another study [19] investigated whether the effect of CBT
on fatigue and functional impairment was mediated by a cognitive
factor (focusing on fatigue) and/or a behavioural factor (activity
avoidance). A decreased tendency to focus on fatigue, but not a de-
creased tendency to avoid activity, was found to be a mediator of
the effect of CBT on patient outcomes. Many studies therefore sug-
gest that the efficacy of CBT for CFS is mediated by changes in cogni-
tions and illness beliefs [17–20]. On the basis of these, but also earlier
studies pointing out that cognitive dimensions were predictors of
treatment effects [21,22], Knoop et al. [23] concluded that cognitions
play a pivotal role in the maintenance of symptoms. More specifical-
ly, these authors' hypothesis is that an increase in physical activity,
which is an important aspect of CBT, leads patients to change their
perception of fatigue (with fatigue again becoming a normal sensa-
tion) and of the relation between fatigue and physical activity (“De-
spite my fatigue, I can be physically active.”), which in turn has a
positive influence upon fatigue-related outcomes. The results of a
more recent study, looking into the mechanisms of change underly-
ing CBT in CFS [24], seem to be in line with this hypothesis. More spe-
cifically, it was found that a path model where cognition acts as a
mediator between behaviour and fatigue was statistically superior
to a model where behaviour acts as a mediator between cognitions
and fatigue.
The question is, however, whether the above mentioned
hypothesis also applies to GET, where the focus of the intervention
is solely on a gradual increase in level of physical activity. One
study evaluating the effect of GET found that, within the intervention
group, changes in illness perceptions, but not changes in fitness,
were related to less fatigue and improved functioning after treat-
ment [25]. Another study, evaluating a pragmatic rehabilitation
intervention focusing upon gradual increases in level of physical
activity, found however that both reductions in limiting behaviour
and reductions in catastrophizing mediated treatment effects on
fatigue [26].
Although the results of the above-mentioned intervention stud-
ies suggest that cognitive factors play a more central role than
behavioural factors in predicting post-treatment fatigue and function-
ing in CFS patients, little is knownabout the role of cognitive and behav-
ioural factors in the natural course of (long-standing) CFS. That is why
we were interested in this study in examining if, and to what extent,
changes in cognitions and behaviours over time predict changes in im-
portant patient outcomes. The research question of this study is there-
fore: “To what extent do changes in cognitions about fatigue (i.e.
illness perceptions) and changes in behavioural factors (i.e. level of
physical activity and behaviour regulation patterns) influence changes
in fatigue severity, number and severity of physical symptoms, and
(physical and emotional) health-related quality of life of CFS patients
over a one-year follow-up period?”2. Methods
2.1. Design
The present study is an observational longitudinal study with a
12 month follow-up. All patients participating in the study gave their
written informed consent. Approval from the Ethical Committee of the
Institute of Psychology at Leiden was obtained (20-1-2010/CEP255).
2.2. Sample
The participants for the study were recruited from a large Dutch pa-
tient organization. Initially an informational email was sent to 1800
members of the organization, containing information on the rationale
and aim of the study. Three hundred and eighteen patients were inter-
ested in participating in the study; 261 patients (82%) filled out the
baseline questionnaires (T1). After baseline measurement, 35 patients
(13.4%) were excluded because they reported to have a chronic disease
that could account for their fatigue and/or because they received psy-
chological or psychiatric treatment for a severe psychiatric disorder.
To check whether all patients in our sample fulfilled the CDC criteria
for CFS [2], they filled out a CDC-based checklist for CFS [27]. As a result,
12 patients were excluded (4.5%). The number of patients at T1 was
thus reduced to 214. At one-year follow-up, 144 patients (67%) filled
out the questionnaires a second time (T2). No significant differences
were found between the patients that participated only at T1 and the




Illness perceptionswere measured using the validated Dutch version
of the Brief Illness Perception Questionnaire (Brief IPQ-DLV) measuring
(perceived) consequences, timeline, identity, personal control, treat-
ment control, coherence, emotional representation, and cause [28].
Causewas notmeasured in this study. Emotional Representation is con-
structed by summing the responses, ranging from 1 to 10, on two items,
Concern and Mood. All other dimensions are measured with a single
item and scored on a scale from1 to 10. For the subscales consequences,
timeline, identity and emotional representation, higher scores represent
more negative illness perceptions (e.g. more consequences or a longer
timeline). For the subscales personal control, treatment control and co-
herence, higher scores represent more positive illness perceptions (e.g.
more personal control or more treatment control). The Brief IPQ was
shown to have good reliability and validity [28,29]. Both the original
IPQ [30] and the brief IPQ discriminate well between patients suffering
from different chronic conditions, including CFS [31].
Physical activitywas determinedwith the Short Questionnaire to As-
sess Health-Enhancing Physical Activity (SQUASH) [32]. Patients were
askedwhether they engaged in physical activity such as walking, biking
or sports and what kind of physical activity they performed. Patients
were also asked to specify the frequency (days per week) and duration
(hours and/orminutes per day) of that physical activity. For every spec-
ified physical activity the frequency (days) was multiplied by the dura-
tion (minutes). The total score for physical activity was calculated by
summing the amount of minutes for all physical activities specified.
Higher scores indicated more minutes of physical activity per week.
The SQUASH has been found to be a reliable and valid questionnaire,
and has been used in adults with chronic conditions, including CFS
[33,34].
Behaviour regulation patterns were assessed with the All-or-nothing
and Limiting behaviour scales from The Behavioural Responses to Illness
Questionnaire (BRIQ) [35]. The first dimension assesses the “boom and
bust pattern” typically observed in CFS and the second dimension as-
sesses the excessive rest that patients take due to their fatigue problems.
Table 1





Age (M, SD) 44.64 (11.89)
Educational level
Primary education 23 16
Secondary education 52 36.1
Higher education 69 47.9
Working status
Working 47 32.6
Not working 97 67.4
Illness duration, years (M, SD) 13.49 (8.27)
Number of additional somatic symptoms (M, SD) 6.18 (1.27)
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all-or-nothing behaviour andmore limiting behaviour, respectively. The
Dutch version of the BRIQ has a very good internal consistency for the
All-or-Nothing behaviour subscale (α= 0.88) and a lower, but accept-
able one for the Limiting behaviour subscale (α= 0.72) [36]. The BRIQ
was designed as a predictive tool for medically unexplained symptoms
and syndromes including CFS following acute infections [35].
2.3.2. Dependent variables
Fatigue Severitywas measured with the Dutch version of the Check-
list of Individual Strength (CIS-20R) [37,38]. The CIS-20R is a reliable
and well-validated 20-item self-report questionnaire assessing four di-
mensions of fatigue: subjective experience of fatigue, lack of concentration,
lack of motivation and activity reduction. The CIS-20 was developed for
CFS patients and has good psychometric properties in this patient
group [37,38]. Items are rated on a 7-point Likert scale ranging from
“Yes, that is true” to “No, that is not true”. For the purpose of the present
study the total fatigue severity score (ranging from20 to 140)was used.
The internal consistency of this total score is excellent (α = 0.90) [37,
38].
Severity of physical symptoms was measured by means of the Pa-
tient Health Questionnaire-15 (PHQ-15), assessing the presence and se-
verity of 15 somatic symptoms [39]. A higher score indicates a higher
level of somatization. The PHQ-15 is a valid and reliable measure of
physical symptoms and is adequate to assess symptom severity in pa-
tients with medically unexplained symptoms and syndromes [40].
Health-related quality of life (QoL). The Short Form Health Survey-12
(SF-12 V.2) [41] was used to assess physical and psychological function-
ing. The SF-12v2 is a well validated measure consisting of 8 domains:
general health perception, physical functioning, role limitations due to
physical problems, bodily pain, vitality, role limitations due to emotion-
al problems, social functioning and mental health. These 8 dimensions
are combined into two sum scores, representing physical functioning
(physical QoL) and psychological functioning (psychological QoL). For
the purpose of the present study, only the sum scores for the two di-
mensions were used. Each sum score ranges from 0 to 100, with higher
scores representing better QoL. The SF-12 has been used in many stud-
ies, also in patients with CFS. The SF-12 is seen as a standardized mea-
sure to assess QoL in CFS patients [42].
2.3.3. Control variables
The demographic variables, gender, age and illness duration were
obtained from the baseline questionnaires.
2.4. Data analysis
Descriptive statistics and frequency analysis were performed to de-
scribe the study sample and the variables included in the study. One-
way repeatedmeasures ANOVAs were conducted to investigate wheth-
er changes in illness perceptions and behavioural variables over time
were statistically significant. In addition to p-values, Confidence Inter-
vals were calculated. To examine whether changes in the independent
variables were clinically relevant, effect sizes (Cohen's d) were calculat-
ed [43].
To answer the central research question, four separate hierarchical
multiple regression analyses were conducted. Fatigue, physical symp-
toms, physical functioning and psychological functioning at follow-up
(T2) were the dependent variables of the regression models. Within
each of the regression models, demographic variables were entered as
control variables in the first block of the model, followed by Illness du-
ration in block two. To control for baseline levels of the outcome vari-
able, the outcome variable at baseline (T1) was entered in the third
block of the regression model. Changes (Δ) in illness perceptions and
changes (Δ) in behaviour from baseline to follow-up (T2-T1) were en-
tered into block four and block five of the regression model, respective-
ly. Only the change variables that were significantly correlated with atleast one outcome variable were entered into the regression models.
Multicollinearity was assessed by examining the relationship between
the independent variables in the Pearson's Correlation analysis and by
calculating the Variance Inflation Factors (VIF) and Tolerance statistics.
The analyses were conducted using SPSS version 21 for windows.
3. Results
Only participantswhomet the CDC criteria at T1 andwho completed
the questionnaires at both time points were included in the study (N=
144). For all variables included in the study, with the exception of phys-
ical activity, b10% of the data was missing (1.3%–8.3%). For these vari-
ables, no missing data techniques were used [44]. For the variable
physical activity, 13.2% of the data was missing. For this variable, miss-
ing values were imputed by means of Mean Imputation.
3.1. Sample characteristics
The demographic characteristics of the sample are shown in Table 1.
Eighty-four percent of the patients were female. The average age was
44.65 (SD = 11.89). Forty-eight percent of the patients completed
higher education. Two thirds of patients were currently not working.
Patients reported an average Illness duration of 13.49 years (ranging
from 1.29 to 40 years).
3.2. Descriptive statistics and univariate analysis
The descriptive statistics and the results of the one-way repeated-
measures ANOVA are displayed in Table 2.
The results of the one-way repeated measures ANOVA showed that
the illness perceptions, consequences, identity, coherence and emotion-
al representation changed significantly over the one-year follow-up pe-
riod. These changes were however not clinically relevant [43]. Of the
behavioural variables, only limiting behaviour changed significantly
over time. This change was clinically relevant, but small [43].
Table 3 shows the results of the correlation analysis between the
change scores of the variables included in the study. The change scores
for (1) consequences, (2) timeline, (3) personal control, (4) identity, (5)
coherence, (6) emotional representation, (7) all-or-nothing behaviour,
and (8) limiting behaviour, were significantly correlated with the
change scores of at least one outcome variable. These change scores
(Δ) were entered as independent variables into the hierarchical multi-
ple regression analysis.
Nomulticollinearity was found between the change scores, included
as independent variables in the hierarchical regression analyses (Table
3). The results of the correlation analysis showed small to large correla-
tion coefficients [45], with the highest correlation being between Δ
identity and Δ consequences (r = 0.56). The results of the VIF and Tol-
erance statistics are reported below.
Table 2
Descriptive statistics and changes in illness perceptions and behavioural variables from baseline (T1) to follow-up (T2).
T1 T2 95% CI of difference F p d
Illness perceptions
Consequence 8.97 (1.33) 8.53 (1.71) 0.18–0.70 11.16 0.001 0.073
Timeline 8.23 (1.75) 8.47 (1.72) −0.49–0.01 3.38 0.068 0.024
Personal control 4.95 (2.07) 5.08 (2.09) −0.46–0.19 0.064 0.420 0.005
Treatment control 4.74 (2.38) 4.74 (2.37) −0.43–0.42 0.00 0.974 0.000
Identity 8.16 (1.33) 7.81 (1.58) 0.12–0.58 9.18 0.003 0.061
Coherence 6.56 (2.34) 5.98 (2.44) 0.12–1.03 6.22 0.014 0.042
Emotional representation 11.94 (4.14) 11.32 (3.85) 0.05–1.21 4.55 0.035 0.031
Behavioural variables
Physical activity 216.16 (231.09) 175.70 (175.72) −2.86–83.78 3.42 0.067 0.165
All-or-nothing behaviour 13.53 (4.34) 13.04 (4.55) −0.22–1.19 1.88 0.172 0.117
Limiting behaviour 20.15 (4.21) 18.75 (4.44) 0.71–2.10 15.85 0.000 0.340
Dependent variables
Fatigue 101.18 (16.31) 97.54 (17.04)
Physical symptoms 13.45 (4.09) 12.79 (4.32)
Physical functioning 36.16 (13.53) 37.85 (15.65)
Psychological functioning 51.87 (14.47) 53.56 (15.86)
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The results of the hierarchical multiple regression analyses for fa-
tigue, physical symptoms, functional status, and psychological function-
ing are displayed in Table 4. All results are reportedwhile controlling for
demographic variables (block 1) and illness duration (block 2). For all
four regression analyses, the VIF and tolerance ranged from 1.00 to
1.57 and 0.64 to 1.00, respectively.
3.3.1. Changes in fatigue
Female gender was significantly associated with a decrease in fa-
tigue from baseline to follow-up. Fatigue at baseline explained 24.7%
of the variance in fatigue at T2. Changes in illness perceptions explained
an additional 14.7% of the variance in fatigue at T2. Increased conse-
quence and identity beliefs over time were significantly and indepen-
dently associated with higher levels of fatigue at T2. Changes in
behavioural variables added 3.5% to the explained variance in fatigue
at T2. Increased scores for All-or-Nothing behaviour over time were as-
sociated with higher levels of fatigue at T2. The total variance explained
by the model was 53.9%.
3.3.2. Changes in physical symptoms
Baseline levels of physical symptoms were significantly associated
with physical symptoms at T2. Physical symptoms at baseline explained
51.8% of the variance in physical symptoms at T2. Changes in illness per-
ceptions explained an additional 9.2% of the variance in physicalTable 3
Correlations between change variables.
1 2 3 4 5 6
1. Δ consequence –
2. Δ timeline 0.22⁎⁎ –
3. Δ personal control −0.24⁎⁎ 0.01 –
4. Δ treatment control 0.09 −0.09 −0.01 –
5. Δ identity 0.56⁎⁎ 0.12 −0.24⁎⁎ 0.03 –
6. Δ coherence −0.12 −0.01 0.27⁎⁎ −0.05 −0.19⁎ –
7. Δ emotional representation 0.23⁎⁎ 0.12 −0.25⁎⁎ 0.04 0.32⁎⁎ −
8. Δ minutes of physical activity −0.03 0.21⁎ 0.06 −0.03 −0.01 −
9. Δ all-or-nothing behaviour 0.19⁎ 0.09 −0.04 0.02 0.06 0.0
10. Δ limiting behaviour 0.23⁎⁎ 0.04 −0.19⁎ −0.06 0.16 −
11. Δ fatigue 0.41⁎⁎ 0.03 −0.22⁎⁎ −0.06 0.39⁎⁎ −
12. Δ physical symptoms 0.27⁎⁎ 0.22⁎ −0.12 −0.02 0.29⁎⁎ 0.0
13. Δ physical functioning −0.34⁎⁎ −0.10 0.25⁎⁎ 0.10 −0.34⁎⁎ 0.1
14. Δ psychological functioning −0.33⁎⁎ −0.14 0.21⁎⁎ 0.07 −0.19⁎ 0.2
⁎ p b 0.05.
⁎⁎ p b 0.01.symptoms at T2. Increased consequence and timeline beliefs over time
were associated with higher physical symptoms at T2. Changes in be-
havioural variables were not significantly associated with physical
symptoms at T2. The total variance explained by the model was 63.0%.
3.3.3. Changes in physical functioning
Physical functioning at baseline explained 44.4% of the variance in
physical functioning at T2. Changes in illness perceptions as a whole ex-
plained an additional 6.8% of the variance in physical functioning at T2.
The individual predictors did, however, not explain enough variance in
the outcome variable, physical functioning, to be statistically significant.
Changes in behavioural variables added 4.6% to the explanation of the
variance in Physical Functioning at T2. Increased scores for both All-
or-Nothing behaviour and Limiting Behaviour over time were associat-
ed with lower physical functioning at T2. The total variance explained
by the model was 58.2%.
3.3.4. Changes in psychological functioning
Psychological functioning at baseline explained 31.4% of the
variance in psychological functioning at T2. Changes in illness
perceptions explained an additional 8.3% of the variance in psycho-
logical functioning at T2. Increased consequence beliefs over time
were associated with lower psychological functioning at T2. Changes
in behavioural variables were not significantly associated with
psychological functioning at T2 (p N 0.05). The total variance
explained by the model was 42.7%.7 8 9 10 11 12 13 14
0.17⁎ –
0.08 0.07 –
6 0.16 −0.01 –
0.04 0.09 −0.09 −0.04 –
0.10 0.17⁎ −0.03 0.25** 0.29⁎⁎ –
1 0.13 −0.11 0.19⁎ 0.14 0.25⁎⁎ –
2 −0.25⁎⁎ 0.10 −0.25⁎⁎ −0.28⁎⁎ −0.36⁎⁎ −0.20⁎⁎ –
1⁎ −0.34⁎⁎ 0.07 −0.16 −0.17⁎ −0.28⁎⁎ −0.23⁎⁎ 0.40⁎⁎ –
Table 4
Hierarchical multiple regression analyses of changes in illness perceptions and behaviour as predictors of change in fatigue, physical symptoms, physical functioning and psychological
functioning.
Fatigue at T2 Physical symptoms at T2 Physical functioning at T2 Psychological functioning at
T2
ΔR2 β ΔR2 β ΔR2 β ΔR2 β
Block 1 (demographic variables) 0.092⁎⁎ 0.004 0.013 0.008
Gender −0.15⁎ −0.07 0.03 0.13
Age 0.09 0.06 −0.15⁎ 0.03
Block 2 (clinical characteristics) 0.018 0.000 0.013 0.017
Illness duration at T1 −0.09 −0.05 0.14 −0.07
Block 3 (dependent at T1) 0.247⁎⁎⁎ 0.58⁎⁎⁎ 0.518⁎⁎⁎ 0.68⁎⁎⁎ 0.444⁎⁎⁎ 0.68⁎⁎⁎ 0.314⁎⁎⁎ 0.62⁎⁎⁎
Block 4 (illness perceptions) 0.147⁎⁎⁎ 0.092⁎⁎ 0.068⁎ 0.083⁎
Δ consequence 0.20⁎ 0.15⁎ −0.09 −0.18⁎
Δ timeline −0.07 0.14⁎ −0.00 −0.04
Δ personal control −0.09 −0.03 0.10 0.05
Δ identity 0.24⁎⁎ 0.11 −0.07 0.06
Δ coherence 0.07 0.09 0.00 0.08
Δ emotional representation −0.09 −0.06 −0.05 −0.15
Block 5 (behaviour) 0.035⁎ 0.015 0.046⁎⁎ 0.006
Δ all-or-nothing behaviour 0.18⁎⁎ 0.12 −0.14⁎ −0.08
Δ limiting behaviour 0.08 0.06 −0.18⁎⁎ 0.01
R2 (adj) 0.539 (0.489) 0.630 (0.588) 0.582 (0.537) 0.427 (0.365)
Δ, change scores between T1 and T2.
⁎ p b 0.05.
⁎⁎ p b 0.01.
⁎⁎⁎ p b 0.001.
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Over a one-year follow-up period, an increase in fatigue severity is
mainly influenced by changes in illness perceptions (an increase in per-
ceived consequences as well as in the number of symptoms attributed
to CFS), and, to a lesser degree, by an increase in the boom-and-bust be-
havioural pattern. In addition, females perceived significantly less fa-
tigue at follow-up. Changes in number and severity of physical
symptoms over the same time period are solely determined by changes
in illness perceptions: higher perceived consequences and a longer ex-
pected duration of CFS independently contribute to an increase in phys-
ical symptoms over time. Both physical and psychological functioning at
follow-up is influenced by changes in illness perceptions over time.
None of the changes in separate illness perceptions however contribute
significantly and independently to physical functioning, whereas worse
psychological functioning at follow-up is determined by an increase in
perceived consequences. In addition, both an increase in all-or-nothing
behaviour and limiting behaviour independently contribute to worse
physical functioning over time. The duration of CFS at baseline (ranging
from1.29 to 40 years) is not related to any of the outcomes at follow-up.
Likewise, changes in level of physical activity over time are not signifi-
cantly associated with any of the outcomes at follow-up.
The above findings clearly point at a differential pattern of associa-
tions between changes in cognitive factors (i.e. illness perceptions)
and behaviour regulation patterns on the one hand, and changes in out-
comes on the other hand. Changes in illness perceptions significantly
contribute to each of the outcomes, but the variance explained by
these changes is higher for fatigue severity at T2 than for the other out-
comes.With the exception of physical functioning, perceivingmore ad-
verse consequences over time contributes to all outcomes. In addition,
attributing more symptoms to CFS predicts more severe fatigue and
expecting a longer illness duration predicts more severe physical symp-
toms at follow-up. Each of these illness perceptions seems to be related
to perceived illness severity. The underlying concept could be a negative
or pessimistic view of the illness, which has a detrimental effect on the
course of the illness. As changes in illness perceptions are too small to be
clinically relevant these findings should however be interpreted with
caution.
Changes in behaviour regulation patterns appear to contribute only
to fatigue severity and to physical functioning. An increase in theboom-and-bust pattern contributes to both higher fatigue severity and
worse physical functioning, whereas an increase in limiting or resting
behaviour only contributes to worse physical functioning at follow-up.
The fact that changes in illness perceptions significantly contribute
to each of the outcomes is in accordance with previous studies [18,25].
The finding that changes in behavioural factors contribute to some,
but not all outcomes, is, however, not in accordance with the results
of earlier studies, with the exception of the pragmatic rehabilitation
study [26], as all other studies demonstrated that changes in behaviour-
al factors did not mediate treatment effects on fatigue [18,19,24]. This
may be explained by differences in both study design andmeasurement
of fatigue. The existing studies that have examined the role of cognitive
and behavioural factors as active ingredients of change were interven-
tion studies aiming at improving fatigue through changing cognitions
and activity patterns, whereas our study is a prospective cohort study,
that looks into the natural evolution of symptoms and functioning
over time. In addition, in the present study, the total fatigue severity
score was used, taking into account the different dimensions that, as a
whole, make up the fatigue concept, whereas other studies only includ-
ed subjective fatigue [18,19], or self-rated improvement of fatigue (YES/
NO) as an outcome [25]. Measuring only subjective fatigue is however
not congruent with the common point of view that fatigue is a multidi-
mensional concept which includes a physical and a mental dimension
[4,38,46,47] as well as a dimension that refers to lack of motivation to
start any activity [4,38,47]. A fatigue severity score should therefore in-
clude all these fatigue dimensions. Using only one dimension, or using a
binary fatigue recovery item as an outcome may, for obvious reasons,
lead to different results.
Changes in level of physical activity are not related to any of the out-
comes. This finding is in accordancewith previous studies, showing that
physical activitywasnot amediator of treatment effect on fatigue sever-
ity in CFS [17,18,48]. The fact that changes in behaviour regulation pat-
terns significantly contributed to both fatigue severity and physical
functioning at follow-up, points to the fact that dysfunctional behav-
ioural patterns are a better predictor of fatigue severity and impaired
functioning than physical activity because they more adequately assess
(im)balance between activity and rest, which is typically related to
physical deconditioning.
With respect to illness perceptions, especially changes in perceived
consequences, identity, and timeline beliefs significantly contribute to
60 V. De Gucht et al. / Journal of Psychosomatic Research 95 (2017) 55–61the outcomes. Most of the studies that looked into the association be-
tween illness perceptions and relevant patient outcomes in CFS were
cross-sectional. The two dimensions most consistently found to be re-
lated to fatigue (or lack of vitality), physical functioning and psycholog-
ical well-being (or distress) were perceivingmore severe consequences
of CFS and attributing a lot of somatic symptoms to CFS [49–51]which is
in accordance with the results of the present study. The few existing
prospective studies were conducted in samples consisting of patients
who were diagnosed with infectious mononucleosis and focused on
predicting if and to what extent illness perceptions were capable of
predicting who developed CF(S) over time [52,53]. To the best of our
knowledge, there are no studies that investigated the contribution of
changes in illness perceptions to progression of fatigue severity and
worsening of physical and psychological functioning in patients with
(long-standing) CFS.
The same accounts for the relationship betweenmaladaptive behav-
iour regulation patterns and patient outcomes in CFS. ‘All-or-nothing
behaviour’, measuring a boom-and-bust pattern of activity, was found
to be themost significant predictor of the development of CFS 6months
after an acute episode of glandular fever [53]. In addition, ‘limiting be-
haviour’, measured post-treatment, mediated the positive effects of a
pragmatic rehabilitation intervention on fatigue at one-year follow-up
in CFS patients [26]. Although both studies point to the potential impor-
tance of maladaptive behaviour regulation patterns in CFS, there are no
observational longitudinal studies that examined their significance for
fatigue-related outcomes in patients who have already been diagnosed
with CFS.4.1. Strengths and limitations of the study
The major strength of this study is the fact that it is a prospective
study in a group of CFS patients that is large enough at follow-up to
test our central hypothesis. Moreover, this is the first study in CFS pa-
tients that has investigated whether ‘natural’ changes in illness percep-
tions, physical activity, and behavioural regulation patterns over a one-
year follow-up period are related to relevant patient outcomes. Despite
this, several remarks can be made with respect to this study.
The follow-up period is only one year. This is an important limitation
of the study. A longer systematic follow-up period of e.g. five years
would (a) most probably show a greater amount of change in both
the predictors and the outcomes over time and (b) allow for a repeated
measures design whereby patients are followed systematically over
time. While we found statistically significant changes over time for
some illness perceptions, none of them are clinically significant. With
respect to the behavioural factors only limiting behaviour showed a
clinically relevant change. A longer follow-up period could remediate
this limitation.
Another important limitation is that this study is conducted in a CFS
population reporting amean disease duration of over 13 years. Changes
in such a population probably require more time and effort than chang-
es in a patient group that was recently diagnosed with CFS. In addition,
the determinants of change may differ between patients with a longer
and a shorter illness duration as suggested by the results of Brown et
al. [54]. Independent of this, a systematic follow-up study starting as
early as possible after thediagnosis of CFS/MEwould be optimal to iden-
tify predictors that can be the target of early interventions as interven-
tions (as e.g. CBT and GET) are probably more effective in changing
perceptions and behaviour in earlier than in later stages of the
syndrome.
In addition, the present study was conducted in patients that were
recruited from a large patient support organization. Previous studies
suggest that these patients may differ from other CFS patients, since
they usually report a higher frequency of CFS-related symptoms [55]
and more psychological distress [56] than persons with CFS in the gen-
eral population. This may limit the generalizability of the results.Finally, in the present study we only examined the contribution of
changes in some cognitive and behavioural factors to patient outcomes.
Future studies should not only extend the number and type of cognitive
(e.g. catastrophizing or self-efficacy) and behavioural factors (e.g. sleep)
that are included, but should also investigate the role of emotional and
social factors, as they could also contribute to changes in patient out-
comes over time [57].
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